{"schema_version":"secwatch.filing_event.v1","accession":"0001402479-23-000005","form_type":"8-K","ticker":null,"cik":"0001402479","company_name":"MedAvail Holdings, Inc.","filed_at":"2023-01-26T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.770638+00:00","generated_at":"2026-06-20T08:04:33.823397+00:00","sec_items":["1.01","2.01","2.02","2.05","8.01","9.01"],"event_type":"m_and_a","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"MedAvail sells SpotRx pharmacy assets to CVS for up to $4.4M; expects ~$2.5M debt post-close","bullets":["Purchase price up to $4.4M; deal expected to close in Q1 2023.","Sells assets from 8 SpotRx pharmacies in AZ, CA, MI, FL.","Estimated year-end 2022 cash/investments $10-11M; remaining debt ~$2.5M after closing.","One-time restructuring costs in H1 2023 ~$6.5M, excluding loan paydown.","Company evaluating financing options, including with existing shareholders."],"urls":{"canonical":"https://secwatch.observer/filing/0001402479-23-000005","json":"https://secwatch.observer/filing/0001402479-23-000005.json","markdown":"https://secwatch.observer/filing/0001402479-23-000005.md","text":"https://secwatch.observer/filing/0001402479-23-000005.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/0001402479-23-000005-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/medavail-20230122.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T08:04:33.823397+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"1f766af3accee25e85f2d14d5088e1a3718347c4","claim":"MedAvail Holdings, Inc. reported preliminary financial results for 2022.","evidence_excerpt":"On January 26, 2022, the Company announced certain preliminary estimates of selected financial results for 2022.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/0001402479-23-000005-index.htm","confidence":0.85,"family_label":"Earnings Releases","details":[{"label":"Period","value":"2022"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"dc4382c2b999853bd04d42c2324f479203b662ca","claim":"MedAvail Holdings, Inc. entered into Asset Purchase and Sale Agreement with German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, \"CVS\") valued at up to $4.4 million (effective 2023-01-22).","evidence_excerpt":"On January 22, 2023, MedAvail Pharmacy, Inc. (the “Company”) entered into the Asset Purchase and Sale Agreement dated January 20, 2023 (the “Asset Purchase Agreement”) with German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, “CVS”), pursuant to which the Company agreed to sell certain of its assets, including pharmacy records, inventory and other assets, in the SpotRx pharmacies located in Tucson and Phoenix, Arizona; Buena Park, Laguna Hills and San Fernando, California; Southfield, Michigan; and in Orlando and Tampa, Florida, for an aggregate purchase price of up to $4.4 million that is payable upon closing (the “CVS Transaction”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/0001402479-23-000005-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"German Dobson CVS, L.L.C., Garfield Beach CVS, L.L.C., Longs Drug Stores California, L.L.C., Woodward Detroit CVS, L.L.C. and Holiday CVS, L.L.C. (collectively, \"CVS\")"},{"label":"Value","value":"up to $4.4 million"},{"label":"Effective","value":"2023-01-22"}],"fact_type":"material_agreement"},{"claim_id":"9b842bbc122c9f011de0cead57412f0bf3b7ad1c","claim":"MedAvail Holdings, Inc. announced a restructuring with charges of approximately $6.5 million affecting pharmacy services business.","evidence_excerpt":"The Company currently estimates that it will incur one-time costs in the first half of 2023 related to the previously announced restructuring to be approximately $6.5 million, excluding the paydown of its existing loan facility.","evidence_source":"SEC 8-K Item 2.05/2.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1402479/000140247923000005/0001402479-23-000005-index.htm","confidence":0.9,"family_label":"Restructurings & Charges","details":[{"label":"Type","value":"restructuring"},{"label":"Charge","value":"approximately $6.5 million"},{"label":"Affected area","value":"pharmacy services business"}],"fact_type":"restructuring_charge"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}